Pangaea Biotech Overview

  • Founded
  • 2007

Founded
  • Status
  • Public

  • Employees
  • 59

Employees
  • Stock Symbol
  • PANG

Stock Symbol
  • Share Price
  • $1.82

  • (As of Thursday Closing)

Pangaea Biotech General Information

Description

Pangaea Oncology SA is a medical services company. The company provides a wide range of services to cancer patients, as well as global pharmaceutical and biotech clients, in the fields of molecular diagnostics, clinical trials, in vitro drug profiling, dx platform validation, and biomarker discovery. The company has aggregated its operations into two segments, Clinical Care division and Diagnostic and Research and Development services division. Clinical Care division delivers medical oncology services and related activities. Diagnostic and Research and Development services division provides diagnostic and in-vitro services.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Laboratory Services (Healthcare)
Stock Exchange
MAD
Primary Office
  • C/Sabino Arana, 5-19
  • 08028 Barcelona
  • Spain
+34 935 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pangaea Biotech Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.82 $1.82 $1.54 - $2.53 $40.8M 22.5M 1.91K -$0.04

Pangaea Biotech Financials Summary

In Thousands,
USD
TTM 31-Dec-2021 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 34,943 34,943 37,017 28,924
Revenue 5,442 5,442 4,673 3,713
EBITDA 171 171 832 (1,917)
Net Income (759) (759) (1,997) (5,419)
Total Assets 23,606 23,606 20,890 18,906
Total Debt 6,064 6,064 8,516 7,874
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Pangaea Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Pangaea Biotech‘s full profile, request access.

Request a free trial

Pangaea Biotech Patents

Pangaea Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3120851-A1 4-amino-6-(2,6-dichlorophenyl)-8-methyl-2-(phenylamino)-pyrido[2,3-d]pyrimidin-7(8h)-one for treatment of solid cancers Withdrawn 21-Jul-2015 0000000000 0
EP-2492688-A1 Molecular biomarkers for predicting response to antitumor treatment in lung cancer Withdrawn 23-Feb-2011 000000000000 00
AU-2011347211-A1 Molecular biomarkers for predicting response to tyrosine kinase inhibitors in lung cancer Abandoned 22-Dec-2010 0000000000
CA-2822474-A1 Molecular biomarkers for predicting response to tyrosine kinase inhibitors in lung cancer Abandoned 22-Dec-2010 0000000000
US-20150038520-A1 Molecular biomarkers for predicting response to tyrosine kinase inhibitors in lung cancer Abandoned 22-Dec-2010 C12Q1/6886
To view Pangaea Biotech’s complete patent history, request access »

Pangaea Biotech Executive Team (3)

Name Title Board Seat Contact Info
Javier Rivela Co-Founder & Chief Executive Officer
Rafael Rosell Ph.D Co-Founder, Chief Scientific Officer, Chairman & Member of Scientific Committee
Santiago Ramon y Cajal MD Co-Founder, Vice-President & Director, Molecular Pathology
To view Pangaea Biotech’s complete executive team members history, request access »

Pangaea Biotech Board Members (5)

Name Representing Role Since
000ú0 00000 000é000 Pangaea Biotech Board Member 000 0000
0000 0000000 00 Pangaea Biotech Board Member 000 0000
000000 0ó000-00é0000 Pangaea Biotech Board Member 000 0000
000000 000000 00.0 Pangaea Biotech Co-Founder, Chief Scientific Officer, Chairman & Member of Scientific Committee 000 0000
00000000 00000 0 00000 00 Pangaea Biotech Co-Founder, Vice-President & Director, Molecular Pathology 000 0000
To view Pangaea Biotech’s complete board members history, request access »

Pangaea Biotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial